These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28225726)

  • 1. COMPUTER ASSISTED RETINAL VESSEL TORTUOSITY EVALUATION IN NOVEL MUTATION FABRY DISEASE: Towards New Prognostic Markers.
    San Román I; Rodríguez ME; Caporossi O; Zoppetti C; Sodi A; Mecocci A; López D; Rodríguez B; Gimeno JR
    Retina; 2017 Mar; 37(3):592-603. PubMed ID: 28225726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer assisted evaluation of retinal vessels tortuosity in Fabry disease.
    Sodi A; Guarducci M; Vauthier L; Ioannidis AS; Pitz S; Abbruzzese G; Sofi F; Mecocci A; Miele A; Menchini U
    Acta Ophthalmol; 2013 Mar; 91(2):e113-9. PubMed ID: 23164241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal vessel tortuosity as a prognostic marker for disease severity in Fabry disease.
    Atiskova Y; Wildner J; Spitzer MS; Aries C; Muschol N; Dulz S
    Orphanet J Rare Dis; 2021 Nov; 16(1):485. PubMed ID: 34801073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement.
    Fledelius HC; Sandfeld L; Rasmussen ÅK; Madsen CV; Feldt-Rasmussen U
    Acta Ophthalmol; 2015 May; 93(3):258-64. PubMed ID: 25487570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
    Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
    Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Fabry disease: prognostic significance of ocular changes for disease severity.
    Kalkum G; Pitz S; Karabul N; Beck M; Pintos-Morell G; Parini R; Rohrbach M; Bizjajeva S; Ramaswami U
    BMC Ophthalmol; 2016 Nov; 16(1):202. PubMed ID: 27852300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted retinal vessel diameter evaluation in Fabry disease.
    Sodi A; Nicolosi C; Vicini G; Lenzetti C; Virgili G; Rizzo S
    Eur J Ophthalmol; 2021 Jan; 31(1):173-178. PubMed ID: 31718270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre.
    Nguyen TT; Gin T; Nicholls K; Low M; Galanos J; Crawford A
    Clin Exp Ophthalmol; 2005 Apr; 33(2):164-8. PubMed ID: 15807825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal hyperreflective foci in Fabry disease.
    Atiskova Y; Rassuli R; Koehn AF; Golsari A; Wagenfeld L; du Moulin M; Muschol N; Dulz S
    Orphanet J Rare Dis; 2019 Dec; 14(1):296. PubMed ID: 31878969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Analysis of Conjunctival and Retinal Vessels in Fabry Disease.
    Sodi A; Lenzetti C; Bacherini D; Finocchio L; Verdina T; Borg I; Cipollini F; Patwary FU; Tanini I; Zoppetti C; Rizzo S; Virgili G
    J Ophthalmol; 2019; 2019():4696429. PubMed ID: 31093369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.
    San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR
    Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cornea verticillata in Fabry disease.
    Moiseev SV; Ismailova DS; Moiseev AS; Bulanov NM; Karovaikina EA; Nosova NR; Fomin VV
    Ter Arkh; 2018 Dec; 90(12):17-22. PubMed ID: 30701828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.
    Altarescu G; Chicco G; Whybra C; Delgado-Sanchez S; Sharon N; Beck M; Elstein D
    J Inherit Metab Dis; 2008 Feb; 31(1):117-23. PubMed ID: 18172744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular signs correlate well with disease severity and genotype in Fabry disease.
    Pitz S; Kalkum G; Arash L; Karabul N; Sodi A; Larroque S; Beck M; Gal A
    PLoS One; 2015; 10(3):e0120814. PubMed ID: 25781336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease.
    Miller JJ; Aoki K; Reid CA; Tiemeyer M; Dahms NM; Kassem IS
    Sci Rep; 2019 Jun; 9(1):9392. PubMed ID: 31253878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease.
    Nilsson M; Kolagari HT; Epstein D; Samolov B; Olsson M; Naess K; Oscarson M; Teaer Fahnehjelm K
    Ophthalmic Genet; 2022 Dec; 43(6):841-849. PubMed ID: 36325813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients.
    Orssaud C; Dufier J; Germain D
    Ophthalmic Genet; 2003 Sep; 24(3):129-39. PubMed ID: 12868031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmological consequences of cyanotic congenital heart disease: vascular parameters and nerve fibre layer.
    Cordina R; Leaney J; Golzan M; Grieve S; Celermajer DS; Graham SL
    Clin Exp Ophthalmol; 2015 Mar; 43(2):115-23. PubMed ID: 25077803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring retinal vessel tortuosity in 10-year-old children: validation of the Computer-Assisted Image Analysis of the Retina (CAIAR) program.
    Owen CG; Rudnicka AR; Mullen R; Barman SA; Monekosso D; Whincup PH; Ng J; Paterson C
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2004-10. PubMed ID: 19324866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P.
    Fukutomi M; Tanaka N; Uchinoumi H; Kanemoto M; Nakao F; Yamada J; Kamei T; Takenaka T; Fujii T
    J Cardiol; 2013 Jul; 62(1):63-9. PubMed ID: 23608164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.